SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending as the community rallies around its potential, touting it as "like Bitcoin but way higher." Discussions center on its cultural relevance and the broader implications of cannabis within emerging markets, with some linking it to the Solana ecosystem.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation around potential marijuana reclassification following reports of a possible executive order. Community discussions revolve around the potential impact on profitability and the possibility of a significant price surge, while some caution about past reverse splits and dilution. The broader cannabis sector is gaining attention as investors anticipate policy changes and their effects on market dynamics.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending as it approaches all-time highs, fueled by optimism surrounding the company's robotaxi initiatives and expansion plans. Bullish sentiment is reflected in options activity, while some traders express skepticism regarding the company's valuation and reliance on future technologies. Community discussions also highlight Elon Musk's influence and the stock's historical volatility, creating a debate between long-term potential and short-term risks.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending as traders discuss its overnight spike and potential catalysts, with some pointing to a potential short squeeze and others highlighting its partnerships and role in AI power solutions. The community is actively debating the reasons behind the stock's recent price action and whether it's undervalued given its growth prospects. Some traders speculate on news related to a partnership with NVDA and potential breakout above consolidation.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SOUN is trending amid discussions of its potential and recent market volatility, particularly in the AI sector. Community members are actively debating the stock's future, analyzing analyst ratings, and speculating on potential catalysts like partnerships, while some express frustration with recent price declines. Others are focusing on upcoming company presentations and perceived short squeezes.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as anticipation builds for an upcoming FDA meeting, with the community actively discussing potential outcomes and speculating on a possible buyout.  Community members are optimistic, referencing strong data and Merck's previous interest, while also watching for news and potential catalysts. Some traders are closely watching volume and share price action.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as investors assess its potential following recent volatility and a dip in price, with many discussing whether it represents a buying opportunity. Community members are weighing bullish analyst target prices against concerns about valuation and a possible SEC probe, creating a debate around the stock's near-term direction. Bullish sentiment revolves around the company's growth potential and AI-driven ad platform, while bears cite overvaluation and regulatory risks.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as traders anticipate potential cannabis rescheduling following reports of a possible executive order. Community members are actively discussing the potential for significant gains, 280e tax implications, and the possible entrance of institutional investors. Some traders are cautious, remembering previous false starts, while others suggest this time feels different.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as community members discuss recent price drops and potential reasons, including Kepler's price target cut and speculation around FDA approval timing for their oral weight loss pill. Some traders express frustration with the stock's performance, while others remain bullish, citing strong fundamentals and potential for long-term growth, particularly with the upcoming pill launch. Discussions also involve competitive pressures from other pharmaceutical companies like Eli Lilly.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors anticipate earnings, with many drawing comparisons to recent volatile reactions to earnings from other tech companies like Broadcom and Oracle. The community is actively discussing the potential for a significant stock movement post-earnings release, driven by high expectations for AI memory demand and pricing. Bullish sentiment remains, fueled by analyst upgrades and positive outlooks on memory prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Braidwell LP Invests $18.77 Million in Sionna Therapeutics, Inc. $SION

Braidwell LP bought a new stake in Sionna Therapeutics, Inc. (NASDAQ:SION - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange...

Sionna Therapeutics (NASDAQ:SION) Upgraded at Wall Street Zen

Wall Street Zen raised Sionna Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...

Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) has been given an average rating of "Moderate Buy" by the eight brokerages that are currently covering the stock, MarketBeat Ratings reports...

Sionna Therapeutics, Inc. $SION Shares Acquired by Prudential Financial Inc.

Prudential Financial Inc. increased its position in shares of Sionna Therapeutics, Inc. (NASDAQ:SION - Free Report) by 114.6% during the second quarter, according to the company in its most recent...

Sionna Therapeutics (NASDAQ:SION) Shares Up 11.4% - What's Next?

Sionna Therapeutics (NASDAQ:SION) Shares Up 11.4% - Time to Buy...

Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - Here's What Happened

Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - Time to Sell...

Royal Bank Of Canada Reiterates "Underperform" Rating for Sionna Therapeutics (NASDAQ:SION)

Royal Bank Of Canada reissued an "underperform" rating and issued a $24.00 price objective on shares of Sionna Therapeutics in a research report on Monday...

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 3.9% - Should You Sell?

Sionna Therapeutics (NASDAQ:SION) Shares Down 3.9% - What's Next...

Peter Thompson Sells 11,890 Shares of Sionna Therapeutics (NASDAQ:SION) Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 11,890 shares of the company's stock in a transaction on Tuesday, November 25th. The stock was sold at an...

Sionna Therapeutics (NASDAQ:SION) Director Sells $4,212,726.82 in Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 94,583 shares of Sionna Therapeutics stock in a transaction on Monday, November 24th. The shares were sold at an...

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

Sionna Therapeutics Inc.

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

SION
Sionna Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SION News

SIONSionna Therapeutics Inc